MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Differential microRNA expression in a cohort of Parkinson’s disease patients

    A. Garvey, N. Cutfield, J. Williams (Dunedin, New Zealand)

    Objective: To develop a blood test that will use micro RNA (miRNA) to identify patients with PD Background: PD is a progressive neurodegenerative disorder and…
  • 2017 International Congress

    Parkinsonism through astrocytic GABA induce motor symptoms

    M.J. Lee, Y. Jang, J. Han, S.J. Kim, J. Kim, I. Ryu, X. Ju, M.J. Ryu, S.-Y. Choi, G.R. Kweon (Daejeon, Republic of Korea)

    Objective: Although reactive gliosis is a prominent feature of PD, its role in pathogenesis has remained elusive. Here we show that aberrantly synthesized GABA from reactive astrocytes tonically inhibits neighboring dopaminergic neuronal firing in SNpc, reducing dopamine production and release, leading to parkinsonian motor symptoms. Background: Parkinsonism is a clinical syndrome of movement abnormalities seen in Parkinson’s disease (PD), which has been attributed to cell-autonomous mechanism of doparminergic neuronal death in the substantia nigra pars compacta (SNpc). Methods: To identify the…
  • 2017 International Congress

    Progressive Supranuclear Palsy : About one case at the Neurology Department – Dakar

    L. Belarabi, K. Toure, M. Ndiaye (Dakar, Senegal)

    Objective: We report an observation of a case received at the consultation in the Neurology Department of National Teaching Hospital Fann. Background: Progressive supranuclear palsy…
  • 2017 International Congress

    An unusual mimicker of Lewy Body Dementia: Gliomatosis Cerebri.

    H. Oliveira, P. Oliveira, V. Calil, P. Macêdo, N. Canedo, L. Vasconcellos (Rio de Janeiro, Brazil)

    Objective: Report a case of rapidly progressive dementia and parkinsonism related to gliomatosis cerebri. Background: Neoplasms may present as parkinsonian syndrome due to impairment of…
  • 2017 International Congress

    Quality of Life in Homebound People with Advanced Parkinson’s Disease: Feasibility and Outcomes of an Interdisciplinary Home Visit Program

    J. Fleisher, M. Sweeney, S. Oyler, A. Lemen, A. Fazl, M. Ko, T. Meisel, N. Friede, G. Dacpano, R. Gilbert, A. Di Rocco, J. Chodosh (New York, NY, USA)

    Objective: 1) To demonstrate the feasibility of an interdisciplinary home visit program (HVP) for advanced Parkinson’s disease (PD) providing expert, interdisciplinary care directly to homebound…
  • 2017 International Congress

    Changes in Functioning Associated with Exercise in Individuals with Parkinson’s

    L. Clack, B. Riemann, M. Cohen (Savannah, GA, USA)

    Objective: The purpose of this study was to assess changes in physical function, cognitive function, and quality of life in individuals with Parkinson’s disease as…
  • 2017 International Congress

    SweetSpot of antidystonic effect in pallidal neurostimulation: a European multicentre imaging study

    M. Reich, L. Lange, J. Roothans, A. Horn, F. Wodarg, J. Runge, M. Aström, F. Steigerwald, K. Witt, R. Nickl, P. Plettig, M. Wittstock, V. Coenen, P. Mahlknecht, W. Poewe, W. Eisner, C. Matthies, A. Kühn, J. Krauss, G. Deuschl*, J. Volkmann* (Wuerzburg, Germany)

    Objective: We investigated Volumes of Tissue activated (VTA) in dystonia subjects under DBS. We aimed to disentangle the SweetSpot for dystonia suppression within the pallidal region.…
  • 2017 International Congress

    Safety and tolerability of deep brain stimulation in early stage Parkinson’s disease: Five-year follow-up of medication use and adverse events

    A. Currie, M. Turchan, L. Heusinkveld, S. Millan, M. Hacker, A. Molinari, C. Gill, T. Davis, P. Konrad, F. Phibbs, P. Hedera, D. Charles (Memphis, TN, USA)

    Objective: To evaluate the long-term safety and tolerability of subthalamic nucleus deep brain stimulation (DBS) for early stage Parkinson’s disease (PD). Background: Twenty-nine subjects with…
  • 2017 International Congress

    Deep Brain Stimulation for Parkinson’s disease: Short-term outcomes, referral patterns and health disparities.

    D. Di Luca, V. Aldahondo, W. Jermakowicks, L. Segala, H. Moore, C. Singer, B. Levin, J. Jagid, C. Luca (Miami, FL, USA)

    Objective: To describe the practice patterns at University of Miami (UM), short term outcomes and health disparities among ethnic groups. Background: Deep brain stimulation (DBS)…
  • 2017 International Congress

    UPDRS benefit from dual frequency DBS fields sculpted by intentionally overlapped interleaving

    Y. Fernandez, D. Caputo, D. Schneider, R. Dipaola, S. Danish, E. Hargreaves (New York, NY, USA)

    Objective: We show that UPDRS-III scores after interleaving compared to those prior to interleaving reflect a gain in benefit by lowered scores. Background: Previously, we…
  • « Previous Page
  • 1
  • …
  • 107
  • 108
  • 109
  • 110
  • 111
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley